Impact of orally disintegrating olanzapine on use of intramuscular antipsychotics, seclusion, and restraint in an acute inpatient psychiatric setting.
Simpson
Joseph R
JR
Thompson
Christopher R
CR
Beckson
Mace
M
D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D011595:Psychomotor Agitation; D011618:Psychotic Disorders / Q000188:drug therapy*; D012149:Restraint, Physical
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine